Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Ibex Technologies Inc. V.IBT

Alternate Symbol(s):  IBXNF

Ibex Technologies Inc is a company engaged in the production and sale of diagnostic products. It manufactures and markets enzymes for biomedical use, through its subsidiaries. It also manufactures and markets a series of arthritis assays which have applications in osteoarthritis research. It sells two product lines namely, Enzymes for in-vitro diagnostics and research, and Tests for osteoarthritis research. The group provides services like Filing and lyophilization of disposable diagnostic components, and Custom fermentation and purification of enzymes for diagnostic companies.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (TSXV:IBT)

Fundamentals Snapshot (TSXV:IBT)

Opinion & Analysis (TSXV:IBT)

No current opinion is available.

Bullboard Posts (TSXV:IBT)

RE:Ibex Reports another Record Quarter

"we expect that sales in the next few quarters will be lower due to a reduction in COVID-related hospitalizations (and therefore...
prophetoffactz - June 10, 2022

Ibex Reports another Record Quarter

  April 30, 2022   2022-06-10 09:00 ET - News Release   MONTREAL, Quebec, June 10, 2022 (GLOBE NEWSWIRE...
nozzpack - June 10, 2022

A nifty little Ibex move re domain name "heparinase.com"

Just noticed .... If you go to https://heparinase.com Ibex's Heparinase page comes up Not sure how long Ibex has had the...
guarantor1 - June 6, 2022

Interesting

Early evidence suggests omicron has not only made Covid reinfection more likely, but also shortened the window in which a past...
ARIMA11 - May 13, 2022

RE:RE:Summary

Can't confirm on $15-$20M. Anyways, it would be best if IBT include in MD&A or investor presenation.
ARIMA11 - May 13, 2022

RE:Summary

From the Summary re Diamaze  "As for DiaMaze, a presentation (22;00) estimated $3-5M in revenue annually." The ...
guarantor1 - May 5, 2022